Part:BBa_K1462520:Design
GAL1+YFP+SH3-lig+ADH1+GAL1+GFP+PDZ-lig+ADH1+GAL1+BFP+GBD-lig+ADH1
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 150
Illegal AgeI site found at 1755
Illegal AgeI site found at 3300 - 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 2804
Design Notes
This part is the final device including the BGY fluorescent protein with the ligand behind. We planned to transmit this device to yeast with the different scale group of GBD,PDZ and SH3 scaffold protein. And we used the confocal to make sure whether the scaffold protein work and the enzyme can be bind on the site of it.
Source
This device is composed of three parts "GAL1 + BFP + GBD ligand + ADH1"[BBa_K1462490],"GAL1 + GFP + BFP ligand + ADH1"[BBa_K1462500] and GAL1 + YFP + SH3 ligand + ADH1[BBa_K1462510].
References
[1] John E Dueber, Gabriel C Wu, G Reza Malmirchegini, et al.Synthetic protein scaffolds provide modular control
over metabolic flux.Nat Biotechnol. 2009 Aug;27(8):753-9.
[2] Schultz, J. et al. Specific interactions between the syntrophin PDZ domain and
voltage-gated sodium channels. Nat Struct Biol 5, 19-24 (1998).
[3] Kim, A.S., Kakalis, L.T., Abdul-Manan, N., Liu, G.A. & Rosen, M.K.
Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome
protein. Nature 404, 151-158 (2000).
[4] Wu, X. et al. Structural basis for the specific interaction of lysine-containing
proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure 3, 215-226 (1995).
[5] Harris, B.Z., Hillier, B.J. & Lim, W.A. Energetic determinants of internal motif
recognition by PDZ domains. Biochemistry 40, 5921-5930 (2001).
[6] Dueber, J.E., Yeh, B.J., Chak, K. & Lim, W.A. Reprogramming control of an
allosteric signaling switch through modular recombination. Science 301, 1904-1908 (2003).
[7] Nguyen, J.T., Turck, C.W., Cohen, F.E., Zuckermann, R.N. & Lim, W.A.
Exploiting the basis of proline recognition by SH3 and WW domains: design of
N-substituted inhibitors. Science 282, 2088-2092 (1998).